Pharma Journalist - Page 909 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Vanda and UCSF Announce License Agreement for CFTR Activators and Inhibitors

Perrigo Completes Divestiture Of Tysabri Royalty Stream For Up To $2.85 Billion

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Bruno Farmaceutici S.p.A.

Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline

Perrigo Completes Divestiture Of Tysabri Royalty Stream For Up To $2.85 Billion

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Bruno Farmaceutici S.p.A.

Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline

Newron Presents Results of Its Phase IIa Study with Evenamide in Patients with Schizophrenia

CHMP provides positive opinion for EU label update for Novo Nordisk’s Tresiba

ShangPharma Announces Strategic Corporate Restructuring of Shanghai ChemPartner